Cardiovascular Disease Drug Market Segment Forecasts Up to 2023,Research Reports-Transparency Market Research

Cardiovascular Disease Drug Market - Global

Industry Analysis, Size, Share, Growth, Trends Single User

and Forecast 2015 - 2023

USD 4315.5









Transparency Market Research

State Tower,

90, State Street, Suite 700.

Albany, NY 12207

United States

www.transparencymarketresearch.com

sales@transparencymarketresearch.com

License:

Flat 10% Discount!!

Free Customization as per your requirement

You will get Custom Report at Syndicated Report

price

Report will be delivered with in 15-20 working days

Request Sample

Buy Now

REPORT DESCRIPTION

Cardiovascular disease (CVD) is a major cause of death in the U.S. and rest of the world. These diseases are primarily related with heart and

blood vessels disorders, such asischemic heart disease, dyslipidemia, stroke, thrombosis, atherosclerosis, coronary artery diseases, peripheral

artery disease and others. These disorders are mainly reported due to obesity, high cholesterol, smoking, excessi alcohol, and poor lifestyle.

According to the World Health Organization (WHO), CVD is responsible for approximately 15 million deaths each year across the globe. The same

source also states that it is a major cause of death in adults and accounts for 50% of total deaths worldwide.

Browse Full Report With TOC:- http://www.transparencymarketresearch.com/cardiovascular-disease-drug-market.html

Cardiovascular diseases can be prevented or treated using various medications. The drugs used for treatment either enhance the pumping

capacity of the heart or increase oxygen supply to the heart. Major drugs prescribed for the treatment of cardiovascular diseases includes heparin,

Coumadin (warfarin), Sectral (acebutolol), Zebeta (bisoprolol), Lopressor, Toprol XL (metoprolol), Norvasc, Lotrel (amlodipine), Vascor (bepridil)

andSular (nisoldipine). The market for cardiovascular drugs can becategorized drug class on the basis of mechanism of action: beta blockers, beta

agonists, alpha blockers, alpha agonists, sodium channel blockers, calcium...